ALOPURINOL BELUPO 100 mg and 200 mg tablets

Size: px
Start display at page:

Download "ALOPURINOL BELUPO 100 mg and 200 mg tablets"

Transcription

1 PACKAGE LEAFLET: INFORMATION FOR THE USER ALOPURINOL BELUPO 100 mg and 200 mg tablets ALOPURINOL This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines the conditions under which the medicine should be used and information on its known safety The product information may be updated several times within its shelf life, and there could be differences between the version of information shown here and other information in the public domain or in the package insert This leaflet may not contain all the information about the medicine or the information may not be the most up to date version for this product If you have any questions or are not sure about anything, ask your doctor or pharmacist Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this leaflet You may need to read it again If you have any further questions, ask your doctor or pharmacist This medicine has been prescribed for you only Do not pass it on to others It may harm them, even if their signs of illness are the same as yours If you get any side effects, talk to your doctor or pharmacist This includes any possible side effects not listed in this leaflet What is in this leaflet? 1. What ALOPURINOL BELUPO is and what it is used for 2. Before you take ALOPURINOL BELUPO 3. How to take ALOPURINOL BELUPO 4. Possible side effects 5. How to store ALOPURINOL BELUPO 6. Further information 1.WHAT ALOPURINOL BELUPO IS AND WHAT IT IS USED FOR Alopurinol Belupo contains a medicine called allopurinol. It works by slowing down certain accelerated chemical reactions that take place in your body. Allopurinol is used for: prevention of gout (disease where the body produces large amounts of uric acid). Uric acid builds up in your joints and tendons in the form of crystals that cause inflammatory reactions. Due to inflammation, the skin around certain joints becomes swollen, painful and sensitive to the slightest touch. Also, severe pain occurs and when moving the affected joints; prevention of other conditions that caused accumulation of uric acid in the body such as the formation of kidney stones and other renal disorders, disorders of the enzyme during the treatment of some cancers. 2. BEFORE YOU TAKE ALOPURINOL BELUPO Warn your doctor if you are taking other medicines, have a chronic disease, a metabolic disorder, you are hypersensitive to medicines or you have had an allergic reaction to some of them.

2 Do not take ALOPURINOL BELUPO in case of if you are hypersensitive (allergic) to allopurinol or to any of the excipients, (see section 6). Take special care with ALOPURINOL BELUPO in you have a liver or kidney disease. Your doctor may give you a lower dose or recommend taking your medicine at intervals longer than one day. Also you will be more carefully and more frequently controlled; you have a heart disease or high blood pressure; you have a current acute attack of gout, which appeared after starting treatment with Alopurinol Belupo tablets; you have a rare form of sugar lactose intolerance. Alopurinol Belupo tablets contain small amounts of lactose. Tell your doctor that you have intolerance to some sugars and be sure to consult with him/her before taking this medicine. In patients using allopurinol there were observed serious and severe skin reactions (hypersensitivity syndrome, Stevens-Jonhson syndrome, and toxic epidermal necrolysis). Often, the rash can include the appearance of sores in the mouth, throat, nose, genitals and eyes (conjunctivitis with red and swollen eyes). These serious skin reactions are often preceded by a condition similar to a cold (flu), followed by fever, headache, pains in the body. The rash may progress; it may cause blisters and peeling of the skin. These serious skin reactions were observed more frequently in patients with impaired liver and kidney function, and with the yellow race (Chinese, Thais). If you experience a rash or above mentioned symptoms, immediately stop taking the medicine allopurinol and contact your doctor. Taking other medicines Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you buy without a prescription and herbal medicines. The following medicines may affect the treatment with Alopurinol tablets: aspirin; theophylline (for asthma); antiepileptics such as phenytoin, carbamazepine (to treat epilepsy); antibiotics e.g., ampicillin / amoxicillin (to treat bacterial infections); didanosine (for the treatment of HIV viral infections); azathioprine, mercaptopurine, cyclophosphamide (for the treatment of malignant disease-cancer); immunosuppressants such as cyclosporine (a medicine that prevents transplant rejection (transplant) authority); antidiabetics e.g. chlorpropamide and tolpropamid (for treating diabetes); ACE inhibitors and diuretics, (for the treatment of high blood pressure and heart disease); coumarin anticoagulants type dicoumarol eg, phenprocoumon, warfarin (to prevent blood clotting); any other medicines for the treatment of gout. Taking food and drink with ALOPURINOL BELUPO tablets It is recommended taking Alopurinol Belupo tablets with food and a glass of water. Pregnancy and breast-feeding Before taking any medicine, consult your doctor or pharmacist. Contact your doctor before taking the medicine Alopurinol Belupo Tablets if you are pregnant, planning to become pregnant or are breast-feeding a baby. It is not recommended taking the medicine Alopurinol Belupo during pregnancy and lactation.

3 Driving and using machines Alopurinol Belupo tablets can cause dizziness, impaired coordination and thus affect the ability to drive and use machines. Do not operate a motor vehicle and do not operate machinery until you know how the medicine affects you. Other warnings In case of intolerance to some sugars, contact your doctor before taking this medicine, as it contains lactose. 3. HOW TO TAKE ALOPURINOL BELUPO Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. Check with your doctor or pharmacist if you are not sure. Swallow the tablets with a glass of water. Take it with food or immediately after meals. Adults The usual starting dose is 100 mg of allopurinol per day and can be increased only in special cases. The following dosing scheme is recommended: 100 to 200 mg daily in mild cases, 300 to 600 mg daily in moderately severe conditions, 700 to 900 mg in severe condition. If dosage per body weight is necessary, a dose of 2-10 mg / kg per day is recommended. Children under 15 years: mg / kg per day to a maximum of 400 mg per day. The use of allopurinol in children is rare, except in the case of malignant diseases (in particular leukemia) and certain enzyme disorders such as Lesch-Nyhan syndrome. Elderly: due to lack of data, should use the lowest dose that provides the necessary reduction of urate concentration. Particular attention should be paid to dosing in case of renal failure (see Dosage in renal failure and Warnings and Precautions). Chronic renal failure In severe renal diseases, dose lower than 100 mg a day or a single dose of 100 mg a day is advised for an extended period of 24 hours. If you need dialysis two or three times a week, dosage of mg of allopurinol, after each dialysis should be considered. Liver disease In patients with liver disease reduced dose of allopurinol should be used. During the early stages of therapy periodic biochemical control of liver function is recommended. Treatment of condition with Uric Acid Nephrolithiasis (neoplasm, Lesch-Nyhan syndrome) The dose of allopurinol should be at the lower limit of the recommended dosage regimen. In case that the formation of stone or other pathological conditions endangered kidney function, should adhere to the advice given in the part of dosing in renal disease. These procedures can reduce the risk of complicating of the clinical picture by deposition of xanthine and / or oxypurinol. If you take more ALOPURINOL BELUPO than you should Contact your doctor. If possible, bring a tablet, this instruction or packaging with you to show the doctor what you have taken.

4 If you forget to take ALOPURINOL Belupo chewable tablets Do not take a double dose to make up for the forgotten tablet. If you forget to take your medicine, take the missed dose the next day at the appointed time, and be sure to tell your doctor about it. If you stop taking ALOPURINOL BELUPO You should not suddenly stop taking the medicine without consulting your doctor. Talk to your doctor or pharmacist if you have any additional questions. 4. POSSIBLE SIDE EFFECTS Like all medicines, ALOPURINOL BELUPO can cause side effects, although not everybody gets them. The following undesirable effects may occur when using allopurinol tablets: Allergic reactions (affects less than 1 in 10,000 patients) In the case of an allergic reaction, stop taking the medicine Alopurinol Belupo tablets and contact your doctor. Symptoms include: skin rash, skin peeling, the occurrence of ulcers or wounds on the lips and in the mouth; rarely may occur whistlingflickering or heaviness in the chest and collapse (fainting). Do not continue taking the tablets unless your doctor tells you otherwise. If you encounter any of the following side effects immediately stop taking the tablets and contact your doctor as soon as possible: Rare (affects less than 1 per 1,000 patients taking the medicine) joint pain or aching swelling in the groin, armpit or neck; yellowing of the skin and whites of the eyes (jaundice); problems with your liver or kidneys; nausea or presence of disease (vomiting), sometimes with traces of blood; changes in the skin in the form of sores in the mouth, throat, nose, genitals and eyes (conjunctivitis, red and swollen eyes), blistering and peeling of the skin; fever and chills, headache, muscle aches (influenza like state) and a feeling of general weakness; bleeding from the lips, eyes, mouth, nose or genitals; severe hypersensitivity reactions, which include fever, skin rash, joint pain and disorders of laboratory blood tests of liver function (it can be a sign of hypersensitivity that affects multiple organs). Very rare (affects less than 1 in 10,000 patients taking the medicine) easier bruising than usual, easier development of sore throat or other signs of infection. Immediately consult your doctor. Occasionally, allopurinol may affect the blood or lymph system. This effect occurs mainly in patients with liver or kidney disease. fever; blood in the urine (haematuria); elevated cholesterol levels in the blood (hyperlipidemia); a general feeling of weakness; weakness, numbness, unsteady on your feet, inability to move the muscles (paralysis) or loss of consciousness; headache, dizziness, drowsiness and visual disturbances; chest pain, high blood pressure and weak pulse; sterility in men or full impotence (erectile impotence); breast enlargement in men and women; changes in normal bowel emptying; taste disturbance;

5 cataract; hair loss or loss of hair color (gray hair); seizures; depression; accumulation of fluid leading to edema (swelling), especially in the joints; feeling of thirst, fatigue and weight loss; This can be signs of diabetes (diabetes mellitus). In this case, your doctor may want to check the level of sugar in your blood. Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. 5. HOW TO STORE ALOPURINOL BELUPO Keep out of the reach and sight of children. Do not use ALOPURINOL BELUPO after the expiry date which is stated on the label. Shelf life: 2 years. Medicines should not be disposed of via waste water or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What ALOPURINOL BELUPO contains The active substance is allopurinol. One Alopurinol Belupo tablet contains 100 mg of allopurinol. One Alopurinol Belupo tablet contains 200 mg of allopurinol. Other ingredients: lactose monohydrate; povidone; starch, corn; magnesium stearate. What ALOPURINOL BELUPO looks like and contents of the pack Alopurinol 100 mg tablet is white, round, flat with beveled edges and without mark on both sides. Alopurinol 100 mg tablets: Immediate packing: white polypropylene vials on which there is a safety lock consisting of white polypropylene caps, stoppers of natural polyethylene color and the security layer (ring) of LD polyethylene and polypropylene inner screw. Outer packaging: folding cardboard box in which there are the white polypropylene bottles with 100 tablets and patient information leaflet. Alopurinol 200 mg tablet is white, round, biconvex, without mark on both sides. Alopurinol 200 mg tablets: Immediate packing: PVC // Al blister, which contains 10 tablets. Outer packaging: folding cardboard box that contains 5 blisters of 10 tablets and patient information leaflet. Regime of dispensing The medicine is issued on doctor`s prescription. Manufacturer BELUPO, DD, Ulica Danica 5, Koprivnica, Croatia

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tipuric 100 & 300 mg Tablets Allopurinol

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tipuric 100 & 300 mg Tablets Allopurinol PACKAGE LEAFLET: INFORMATION FOR THE USER Tipuric 100 & 300 mg Tablets Allopurinol Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Allopurinol 100mg and 300mg Tablets (Allopurinol)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Allopurinol 100mg and 300mg Tablets (Allopurinol) PACKAGE LEAFLET: INFORMATION FOR THE USER Allopurinol 100mg and 300mg Tablets (Allopurinol) Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package leaflet: Information for the user. Allopurinol Orion 300 mg tablets. allopurinol

Package leaflet: Information for the user. Allopurinol Orion 300 mg tablets. allopurinol Package leaflet: Information for the user Allopurinol Orion 100 mg tablets Allopurinol Orion 300 mg tablets allopurinol Read all of this leaflet carefully before you start taking this medicine because

More information

Package leaflet: Information for the patient. Allopurinol Mylan 300 mg tablets. allopurinol

Package leaflet: Information for the patient. Allopurinol Mylan 300 mg tablets. allopurinol Package leaflet: Information for the patient 100 mg tablets 300 mg tablets allopurinol Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets RANITIDINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information

More information

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Fucidin 250 mg Tablets sodium fusidate Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol Patient leaflet: Information for the user Paracetamol Galpharm 500mg tablets paracetamol [For medicines available only on prescription:] Read all of this leaflet carefully before you start taking this

More information

HERNOVIR 200 mg tablets

HERNOVIR 200 mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER HERNOVIR 200 mg tablets ACICLOVIR This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information

How it works. Use in children

How it works. Use in children GenRx Allopurinol contains the active ingredient, (al-oe-pur-in-ol) For a copy of a large print leaflet, Ph: 1800 195 055 Consumer Medicine Information What is in this leaflet Read this leaflet carefully

More information

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read

More information

Package leaflet: Information for the patient. Alopur 100 mg Tablets Alopur 300 mg Tablets. allopurinol

Package leaflet: Information for the patient. Alopur 100 mg Tablets Alopur 300 mg Tablets. allopurinol Package leaflet: Information for the patient Alopur 100 mg Tablets Alopur 300 mg Tablets allopurinol Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Irbenida H 150mg/12,5mg film-coated tablets

Irbenida H 150mg/12,5mg film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Irbenida H 150mg/12,5mg film-coated tablets IRBESARTAN/HYDROCHLOROTHIAZIDE This leaflet is a copy of the Summary of Product Characteristics and Patient Information

More information

Coldrex MaxGrip Lemon Powder for oral solution

Coldrex MaxGrip Lemon Powder for oral solution PACKAGE LEAFLET: INFORMATION FOR THE USER Coldrex MaxGrip Lemon Powder for oral solution PARACETAMOL, PHENYLEPHRINE, ASCORBIC ACID This leaflet is a copy of the Summary of Product Characteristics and Patient

More information

METHYLDOPA 250 mg Film-coated Tablets

METHYLDOPA 250 mg Film-coated Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER METHYLDOPA 250 mg Film-coated Tablets METHYLDOPA This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets

Package leaflet: Information for the patient. Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets Package leaflet: Information for the patient Acetylsalicylic acid Bluefish 75 mg tablets Acetylsalicylic acid Bluefish 160 mg tablets Acetylsalicylic acid Read all of this leaflet carefully before you

More information

BACTRIM tablets PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1 WHAT BACTRIM IS AND WHAT IT IS USED FOR

BACTRIM tablets PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1 WHAT BACTRIM IS AND WHAT IT IS USED FOR PACKAGE LEAFLET: INFORMATION FOR THE USER BACTRIM tablets CO-TRIMOXAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Fucidin 250 mg/5 ml Oral Suspension fusidic acid Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Dulcolax 5 mg, film-coated tablets

Dulcolax 5 mg, film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Dulcolax 5 mg, film-coated tablets BISACODYL This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which

More information

NEOFEN 60 mg suppository

NEOFEN 60 mg suppository PACKAGE LEAFLET: INFORMATION FOR THE USER NEOFEN 60 mg suppository IBUPROFEN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Aciclovir 400 mg Tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this

More information

ATORIS 10, 20, 40 mg film-coated tablets

ATORIS 10, 20, 40 mg film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER ATORIS 10, 20, 40 mg film-coated tablets ATORVASTATIN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen PACKAGE LEAFLET: INFORMATION FOR THE USER EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS Ibuprofen Read all of this leaflet carefully before you start taking Easofen Max Strength Tablets because it contains

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 7 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Aciclovir 200 mg Tablets 1 Aciclovir Read all of this leaflet carefully before you start taking this medicine.

More information

Package leaflet: Information for the patient. Captopril 12.5mg Tablets Captopril 25mg Tablets Captopril 50mg Tablets (captopril)

Package leaflet: Information for the patient. Captopril 12.5mg Tablets Captopril 25mg Tablets Captopril 50mg Tablets (captopril) Package leaflet: Information for the patient Captopril 12.5mg Tablets Captopril 25mg Tablets Captopril 50mg Tablets (captopril) Read all of this leaflet carefully before you start taking this medicine

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium PACKAGE LEAFLET: INFORMATION FOR THE USER Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium Read all of this leaflet carefully before you start taking this medicine because it contains

More information

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets

Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Irbenida 150 mg film-coated tablets; 300 mg film-coated tablets IRBESARTAN This leaflet is a copy of the Summary of Product Characteristics and Patient Information

More information

TREANA 5mg and 10mg Film-coated Tablets

TREANA 5mg and 10mg Film-coated Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER TREANA 5mg and 10mg Film-coated Tablets OLANZAPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Package leaflet: Information for the user Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir

Aciclovir Apotex 200 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir Package leaflet: Information for the user Aciclovir Apotex 200 mg tabletten Aciclovir Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate PACKAGE LEAFLET Package leaflet: Information for the patient Calcium Folinate 15 mg Tablets calcium folinate Read all of this leaflet carefully before you start taking this medicine because it contains

More information

SPASMEX FORTE 5mg tablets

SPASMEX FORTE 5mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER SPASMEX FORTE 5mg tablets TROSPIUM This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin Package leaflet: Information for the user Dalmevin 50 mg tablets Vildagliptin Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

Package Leaflet: Information for the User Mercaptopurine 50mg tablets 6-mercaptopurine

Package Leaflet: Information for the User Mercaptopurine 50mg tablets 6-mercaptopurine Package Leaflet: Information for the User Mercaptopurine 50mg tablets 6-mercaptopurine Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide) Package leaflet: Information for the patient Bumetanide 1 mg and 5 mg Tablets (bumetanide) Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

NORVASC 5 mg and 10 mg tablets

NORVASC 5 mg and 10 mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER NORVASC 5 mg and 10 mg tablets AMLODIPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which

More information

Lovastatin tablets 20 and 40 mg PACKAGE LEAFLET

Lovastatin tablets 20 and 40 mg PACKAGE LEAFLET PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Lovastatin Mylan 20 mg Tablets Lovastatin Mylan 40 mg Tablets lovastatin Read all of this leaflet carefully before you start taking this medicine.

More information

1. What Betahistine dihydrochloride tablets is and what it is used for

1. What Betahistine dihydrochloride tablets is and what it is used for Package leaflet: Information for the user Betahistine dihydrochloride 8 mg tablets Betahistine dihydrochloride 16 mg tablets Betahistine dihydrochloride Read all of this leaflet carefully before you start

More information

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Ca-C 1000 Calvive 1000 mg + 327 mg + 1000 mg effervescent tablets CALCIUM LACTATE GLUCONATE, CALCIUM CARBONATE, ASCORBIC ACID (VITAMIN C) This leaflet is a copy

More information

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine Package leaflet: Information for the user Ebateva 10 mg Orodispersible Tablets Ebateva 20 mg Orodispersible Tablets Ebastine Read all of this leaflet carefully before you start taking this medicine because

More information

Aciclovir Apotex 800 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir

Aciclovir Apotex 800 mg tabletten RVG Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir Package leaflet: Information for the user Aciclovir Apotex 800 mg tabletten Aciclovir Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin

PACKAGE LEAFLET: INFORMATION FOR THE USER. XIFAXANTA 200 mg film-coated tablets Rifaximin PACKAGE LEAFLET: INFORMATION FOR THE USER XIFAXANTA 200 mg film-coated tablets Rifaximin Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Irbesartan 75mg Film-coated Tablets Irbesartan 150mg Film-coated Tablets Irbesartan 300mg Film-coated Tablets irbesartan Read all of this leaflet carefully before

More information

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC. SCHEDULING STATUS: S4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNAFLOC 250 (tablets) DYNAFLOC 500 (tablets) DYNAFLOC 750 (tablets) Read this entire leaflet carefully before you start taking

More information

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir Package leaflet: Information for the user Famvir 125, 250 and 500 mg film-coated tablets famciclovir Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone

Package leaflet: Information for the patient. Dexametason Abcur 4 mg tablets. Dexamethasone Package leaflet: Information for the patient Dexametason Abcur 1 mg tablets Dexametason Abcur 4 mg tablets Dexamethasone Read all of this leaflet carefully before you start taking this medicine because

More information

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET PROPOSED PATIENT INFORMATION LEAFLET FOR PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET SCHEDULING STATUS S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PHARMA DYNAMICS CLOPIDOGREL

More information

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide Package leaflet: Information for the user Burinex 5 mg Tablets bumetanide Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets. Alfuzosin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets. Alfuzosin hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Alfuzosin Sandoz 5 mg, prolonged-release tablets Alfuzosin hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains

More information

Package leaflet: Information for the user. Fluvastatin

Package leaflet: Information for the user. Fluvastatin Package leaflet: Information for the user Lescol XL 80 mg prolonged-release tablets Fluvastatin Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Package Leaflet: Information for the User

Package Leaflet: Information for the User Package Leaflet: Information for the User Imuran Tablets Azathioprine Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read it again. If you

More information

Clonamox 250mg Hard Capsules Clonamox 500mg Hard Capsules

Clonamox 250mg Hard Capsules Clonamox 500mg Hard Capsules Package Leaflet: Information for the User Clonamox 250mg Hard Capsules Clonamox 500mg Hard Capsules Amoxicillin Read all of this leaflet carefully before you start taking this medicine becuase it contains

More information

Package Leaflet: Information for the User. Clonamox 125 mg/5 ml Powder for Oral Suspension Clonamox 250 mg/5 ml Powder for Oral Suspension

Package Leaflet: Information for the User. Clonamox 125 mg/5 ml Powder for Oral Suspension Clonamox 250 mg/5 ml Powder for Oral Suspension Package Leaflet: Information for the User Clonamox 125 mg/5 ml Powder for Oral Suspension Clonamox 250 mg/5 ml Powder for Oral Suspension Amoxicillin Read all of this leaflet carefully before you start

More information

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any

More information

SULFASALAZIN 500mg enteric-coated tablets

SULFASALAZIN 500mg enteric-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER SULFASALAZIN 500mg enteric-coated tablets SULFASALAZINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a

More information

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine PACKAGE LEAFLET: INFORMATION FOR THE PATIENT ILAXTEN 20 MG TABLETS bilastine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine

Package leaflet: Information for the patient. Felodipin AstraZeneca 10 mg prolonged-release tablets. felodipine Package leaflet: Information for the patient Felodipin AstraZeneca 2.5 mg prolonged-release tablets Felodipin AstraZeneca 5 mg prolonged-release tablets Felodipin AstraZeneca 10 mg prolonged-release tablets

More information

PATIENT INFORMATION LEAFLET AMLOC RANGE

PATIENT INFORMATION LEAFLET AMLOC RANGE SCHEDULING STATUS: S3 PROPRIETARY NAME AND DOSAGE FORM: AMLOC 5 mg tablets AMLOC 10 mg tablet Read all of this leaflet carefully before you start taking AMLOC. Keep this leaflet. You may need to read it

More information

LYSOBACT COMPLETE SPRAY ( ) mg / ml Oromucosal spray, solution

LYSOBACT COMPLETE SPRAY ( ) mg / ml Oromucosal spray, solution PACKAGE LEAFLET: INFORMATION FOR THE USER LYSOBACT COMPLETE SPRAY (20 + 1.5 + 0.5) mg / ml Oromucosal spray, solution LYSOZYME, CETYLPYRIDINIUM, LIDOCAINE This leaflet is a copy of the Summary of Product

More information

Package leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets.

Package leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets. Package leaflet: Information for the patient Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets Torasemide Read all of this leaflet carefully before you start taking

More information

Package leaflet: Information for the patient. Ezetimibe 10 mg tablets ezetimibe

Package leaflet: Information for the patient. Ezetimibe 10 mg tablets ezetimibe Package leaflet: Information for the patient Ezetimibe 10 mg tablets ezetimibe Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide

Package leaflet: Information for the user. Flutamid Stada 250 mg tablets Flutamide Package leaflet: Information for the user Flutamid Stada 250 mg tablets Flutamide Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

SINGULAIR JUNIOR 5mg chewable tablets

SINGULAIR JUNIOR 5mg chewable tablets PACKAGE LEAFLET: INFORMATION FOR THE USER SINGULAIR JUNIOR 5mg chewable tablets MONTELUKAST This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

Package Leaflet: Information for the User Daraprim 25 mg tablets pyrimethamine

Package Leaflet: Information for the User Daraprim 25 mg tablets pyrimethamine Package Leaflet: Information for the User Daraprim 25 mg tablets pyrimethamine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline

Package leaflet: Information for the patient. Lymelysal 300 mg hard capsules. lymecycline equivalent to 300 mg tetracycline Package leaflet: Information for the patient Lymelysal 300 mg hard capsules lymecycline equivalent to 300 mg tetracycline Read all of this leaflet carefully before you start taking this medicine because

More information

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin

Package leaflet: Information for the user. Floxapen 250 mg & 500 mg Capsules. Flucloxacillin Package leaflet: Information for the user Floxapen 250 mg & 500 mg Capsules Flucloxacillin Read all of this leaflet carefully before you start using this medicine because it contains important information

More information

Package leaflet: Information for the user. Octasa 800 mg Modified Release Tablets Active substance: mesalazine

Package leaflet: Information for the user. Octasa 800 mg Modified Release Tablets Active substance: mesalazine Package leaflet: Information for the user Octasa 800 mg Modified Release Tablets Active substance: mesalazine Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.

More information

Progout contains the active ingredient allopurinol

Progout contains the active ingredient allopurinol Progout contains the active ingredient allopurinol CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Progout. It does not contain all the available

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides

Package leaflet: Information for the user. SenEase 7.5 mg tablets. Sennosides Package leaflet: Information for the user SenEase 7.5 mg tablets Sennosides Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 7 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Aciclovir Tablets USP 400 mg * Aciclovir 400 mg Tablets Read all of this leaflet carefully before you start

More information

XYZAL 5 MG FILM-COATED TABLET

XYZAL 5 MG FILM-COATED TABLET XYZAL 5 MG FILM-COATED TABLET Levocetirizine dihydrochloride Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However,

More information

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR PACKAGE LEAFLET: INFORMATION FOR THE USER Oxcarbazepine 150/300/600 mg Film-Coated Tablets (Oxcarbazepine) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Methotrexate 10 mg Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Methotrexate 10 mg Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Methotrexate 10 mg Tablets Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Keep this

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate) PACKAGE LEAFLET: INFORMATION FOR THE USER ZADITEN 1 mg/5 ml Oral Solution Ketotifen (as Ketotifen hydrogen fumarate) Read all of this leaflet carefully because it contains important information for you.

More information

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol) Package leaflet: Information for the user Colecalciferol 3000 IU/ml Oral Solution (colecalciferol) Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

PACKAGE LEAFLET Package leaflet: Information for the user. Ranitidin Actavis 150 mg and 300 mg film-coated tablets. Ranitidine

PACKAGE LEAFLET Package leaflet: Information for the user. Ranitidin Actavis 150 mg and 300 mg film-coated tablets. Ranitidine PACKAGE LEAFLET Package leaflet: Information for the user Ranitidin Actavis 150 mg and 300 mg film-coated tablets Ranitidine Read all of this leaflet carefully, before you start taking this medicine because

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET CRESTOVAS (ROSUVASTATIN 5MG, 10MG, 20MG & 40MG, TABLETS USP) Please read this leaflet carefully before you start to take your medicine. It contains important information. Keep

More information

Pyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET.

Pyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET. PACKAGE LEAFLET Page 1 of 6 PACKAGE LEAFLET: INFORMATION FOR THE USER Pyrazinamide 500 mg Tablets * Pyrazinamide Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet.

More information

FLUIMUKAN PLUS 600 mg effervescent tablets

FLUIMUKAN PLUS 600 mg effervescent tablets PACKAGE LEAFLET: INFORMATION FOR THE USER FLUIMUKAN PLUS 600 mg effervescent tablets Acetylcysteine This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for

More information

Dorzolamide 20 mg/ml Eye Drops, Solution

Dorzolamide 20 mg/ml Eye Drops, Solution PACKAGE LEAFLET: INFORMATION FOR THE USER Dorzolamide 20 mg/ml Eye Drops, Solution (Dorzolamide hydrochloride) Read all of this leaflet carefully before you start using this medicine because it contains

More information

OSPEN 1000; OSPEN ,000,000 IU film-coated tablets; 1,500,000 IU film-coated tablet

OSPEN 1000; OSPEN ,000,000 IU film-coated tablets; 1,500,000 IU film-coated tablet PACKAGE LEAFLET: INFORMATION FOR THE USER OSPEN 1000; OSPEN 1500 1,000,000 IU film-coated tablets; 1,500,000 IU film-coated tablet PHENOXYMETHYLPENICILLIN; PHENOXYMETHYLPENICILLIN This leaflet is a copy

More information

What Amoxil is Amoxil is an antibiotic. The active ingredient is amoxicillin. This belongs to a group of medicines called penicillins.

What Amoxil is Amoxil is an antibiotic. The active ingredient is amoxicillin. This belongs to a group of medicines called penicillins. Amoxil Capsules 250 mg and 500 mg amoxicillin Package leaflet: Information for the user Amoxil Capsules 250 mg and 500 mg amoxicillin Read all of this leaflet carefully before you start taking this medicine

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Dalacin C 150mg Capsules clindamycin hydrochloride PFIZER Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

PATIENT INFORMATION LEAFLET TEXAMER

PATIENT INFORMATION LEAFLET TEXAMER SCHEDULING STATUS: S2 PROPRIETARY NAME AND DOSAGE FORM: film-coated tablets Read all of this leaflet carefully because it contains important information for you. is available without a doctor s prescription,

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PPM Code: E1981 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S2 PROPRIETARY NAME DOSAGE FORM: film coated tablets Read all of this leaflet carefully because it contains important information for you.

More information

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics. Package Leaflet: Information for the User Zofran 4 mg or 8 mg Film coated Tablets Ondansetron Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate) PACKAGE LEAFLET: INFORMATION FOR THE USER DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate) Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need

More information

Motens 2 mg and 4 mg Tablets lacidipine

Motens 2 mg and 4 mg Tablets lacidipine Package leaflet: Information for the user Motens 2 mg and 4 mg Tablets lacidipine Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

2 What you need to know before you take Zantac

2 What you need to know before you take Zantac Package leaflet: Information for the user Zantac Tablets 150 mg and 300 mg ranitidine hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Repaglinide Accord 0.5 mg tablets Repaglinide Accord 1 mg tablets Repaglinide Accord 2 mg tablets Repaglinide Read all of this leaflet carefully before you start

More information

Asacolon 400 mg and 800 mg Gastro-resistant Tablets

Asacolon 400 mg and 800 mg Gastro-resistant Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Asacolon 400 mg and 800 mg Gastro-resistant Tablets Mesalazine Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

REDERGIN 1.5 mg tablets; 4.5 mg tablets; 1 mg/ml oral solution

REDERGIN 1.5 mg tablets; 4.5 mg tablets; 1 mg/ml oral solution PACKAGE LEAFLET: INFORMATION FOR THE USER REDERGIN 1.5 mg tablets; 4.5 mg tablets; 1 mg/ml oral solution ERGOLOID MESYLATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information

More information

Package leaflet: Information for the user. Ezetimibe STADA 10 mg, tabletten. Ezetimibe

Package leaflet: Information for the user. Ezetimibe STADA 10 mg, tabletten. Ezetimibe Package leaflet: Information for the user Ezetimibe STADA 10 mg, tabletten Ezetimibe Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

PATIENT INFORMATION LEAFLET. ZITHROMAX 250mg Capsules azithromycin

PATIENT INFORMATION LEAFLET. ZITHROMAX 250mg Capsules azithromycin PATIENT INFORMATION LEAFLET ZITHROMAX 250mg Capsules azithromycin Read all of this leaflet carefully before you start taking this medicine Keep this leaflet. You may need to read it again. If you have

More information